{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:22:19Z","timestamp":1787160139537,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Fibrinolysis phenotypes are integral in the pathogenesis of trauma-induced coagulopathy and its sequelae. Of the various phenotypes of dysregulated fibrinolysis, hyperfibrinolysis (HF) is most associated with the highest mortality and has been implicated directly in death due to bleeding. While the dominant regulators of fibrinolysis are well established, additional yet crucial candidate biomediators of HF are less known. Thus, our hypothesis is that the early proteomic signature of HF would expand our comprehension of this dysregulated pathway after severe trauma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Mass spectrometry\u2013based proteomics methods were leveraged to characterize plasma samples from trauma patients enrolled in the Control of Major Bleeding After Trauma randomized control trial. In this post hoc analysis, the plasma fraction of samples collected at the emergency department from highly injured, hypotensive patients in HF was subjected to proteomics workflows. Projection to latent structures and principal component analyses were performed using rapid thromboelastogram-based percent decrease in clot strength 30 minutes after it reaches its maximum amplitude to identify statistically significant proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Fibrinogen \u03b3\u2032 (odds ratio [OR], 21.85;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.001) and Golgi casein kinase (FAM20C) (OR, 4.25;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.025) were among the top proteins most associated with HF. Other significant proteins included phospholipid transfer protein (OR, 2.39;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.025) and 3-hydroxy-3-methylglutaryl coenzyme A synthase (OR, 217.36;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.003). Proteins least associated with decreased HF included complement proteins, coagulation factors, and other procoagulant proteins such as thrombin-activatable fibrinolysis inhibitor (OR, 0.394;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.011) and actin \u03b2 (OR, 0.732;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.027).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Cutting-edge proteomic analyses have uncovered potential biomediators of HF, a novel yet crucial next step in understanding these maladaptive syndromes. This provides a platform to characterize numerous additional proteins associated with HF from where we can start investigating potential therapeutic targets as the next step in treating HF and thus trauma-induced coagulopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n                    <jats:p>Prognostic and Epidemiological; Level IV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000004792","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T15:00:27Z","timestamp":1760972427000},"page":"460-468","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Thromboinflammatory mediators produced by hyperfibrinolysis following injury"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7703-1751","authenticated-orcid":false,"given":"Otto","family":"Thielen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry R.","family":"Schaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ramser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchayita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"6","key":"bib1-20260309","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TA.0000000000000341","article-title":"Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy","volume":"77","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"bib2-20260309","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-021-00264-3","article-title":"Trauma-induced coagulopathy","volume":"7","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"9771","key":"bib3-20260309","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","year":"2011","journal-title":"Lancet"},{"issue":"Suppl 2","key":"bib4-20260309","first-page":"S110","article-title":"Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient","volume":"56 Suppl 2","year":"2016","journal-title":"Transfusion"},{"issue":"23\u201324","key":"bib5-20260309","first-page":"e2200112","article-title":"Portable mass spectrometry system: instrumentation, applications, and path to 'omics analysis","volume":"22","year":"2022","journal-title":"Proteomics"},{"issue":"10144","key":"bib6-20260309","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(18)31553-8","article-title":"Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"bib7-20260309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.surg.2014.05.021","article-title":"Exploring ethical conflicts in emergency trauma research: the COMBAT (Control of Major Bleeding after Trauma) study experience","volume":"157","year":"2015","journal-title":"Surgery"},{"issue":"23","key":"bib8-20260309","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"bib9-20260309","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2015.05.028","article-title":"A single kinase generates the majority of the secreted phosphoproteome","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"3","key":"bib10-20260309","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2141.2007.06825.x","article-title":"Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway","volume":"139","year":"2007","journal-title":"Br J Haematol"},{"issue":"18","key":"bib11-20260309","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1021\/bi00313a033","article-title":"Gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing","volume":"23","year":"1984","journal-title":"Biochemistry"},{"issue":"1","key":"bib12-20260309","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1538-7836.2003.00027.x","article-title":"Fibrinogen gamma' chain binds thrombin exosite II","volume":"1","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"2","key":"bib13-20260309","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood.V67.2.385.385","article-title":"Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length","volume":"67","year":"1986","journal-title":"Blood"},{"issue":"22","key":"bib14-20260309","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.1074\/jbc.272.22.14251","article-title":"Resistance of gammaA\/gamma' fibrin clots to fibrinolysis","volume":"272","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"bib15-20260309","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/01.ATV.0000109748.77727.3e","article-title":"Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate","volume":"24","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"bib16-20260309","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2012.04717.x","article-title":"Evidence that fibrinogen gamma' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness","volume":"10","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"13","key":"bib17-20260309","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels","volume":"106","year":"2005","journal-title":"Blood"},{"issue":"1","key":"bib18-20260309","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2007.03.007","article-title":"The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis","volume":"121","year":"2007","journal-title":"Thromb Res"},{"issue":"10","key":"bib19-20260309","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/j.1460-2075.1989.tb08447.x","article-title":"Multiple domains of the large fibroblast proteoglycan, versican","volume":"8","year":"1989","journal-title":"EMBO J"},{"issue":"1","key":"bib20-20260309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12871-021-01300-1","article-title":"Glycocalyx components affect platelet function, whole blood coagulation, and fibrinolysis: an in vitro study suggesting a link to trauma-induced coagulopathy","volume":"21","year":"2021","journal-title":"BMC Anesthesiol"},{"issue":"12","key":"bib21-20260309","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1055\/s-0038-1675228","article-title":"Plasma phospholipid transfer protein promotes platelet aggregation","volume":"118","year":"2018","journal-title":"Thromb Haemost"},{"key":"bib22-20260309","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12959-015-0054-0","article-title":"Inhibition of thrombin generation in human plasma by phospholipid transfer protein","volume":"13","year":"2015","journal-title":"Thromb J"},{"issue":"5","key":"bib23-20260309","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1194\/jlr.R082503","article-title":"Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis","volume":"59","year":"2018","journal-title":"J Lipid Res"},{"issue":"3","key":"bib24-20260309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11883-021-00907-6","article-title":"The role of phospholipid transfer protein in the development of atherosclerosis","volume":"23","year":"2021","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"bib25-20260309","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2010.03744.x","article-title":"The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes","volume":"8","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"bib26-20260309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1871529X1402140807144435","article-title":"Phospholipid transfer protein in diabetes, metabolic syndrome and obesity","volume":"14","year":"2014","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"8","key":"bib27-20260309","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/09537104.2022.2078488","article-title":"Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength","volume":"33","year":"2022","journal-title":"Platelets"},{"issue":"10","key":"bib28-20260309","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.4049\/jimmunol.1002185","article-title":"Collectin 11 (CL-11, CL-K1) is a MASP-1\/3-associated plasma collectin with microbial-binding activity","volume":"185","year":"2010","journal-title":"J Immunol"},{"key":"bib29-20260309","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12915-015-0136-2","article-title":"Molecular basis of sugar recognition by collectin-K1 and the effects of mutations associated with 3MC syndrome","volume":"13","year":"2015","journal-title":"BMC Biol"},{"issue":"4","key":"bib30-20260309","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.molimm.2013.07.011","article-title":"Characterization of the interaction between collectin 11 (CL-11, CL-K1) and nucleic acids","volume":"56","year":"2013","journal-title":"Mol Immunol"},{"issue":"5","key":"bib31-20260309","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/TA.0000000000003713","article-title":"Postinjury complement C4 activation is associated with adverse outcomes and is potentially influenced by plasma resuscitation","volume":"93","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"issue":"11","key":"bib32-20260309","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/j.1460-2075.1986.tb04582.x","article-title":"Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity","volume":"5","year":"1986","journal-title":"EMBO J"},{"issue":"5","key":"bib33-20260309","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/SHK.0000000000002220","article-title":"Metabolomic and proteomic changes in trauma-induced hypocalcemia","volume":"60","year":"2023","journal-title":"Shock"},{"issue":"1","key":"bib34-20260309","first-page":"189","article-title":"On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component","volume":"94","year":"1993","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"bib35-20260309","first-page":"159","article-title":"Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins","volume":"120","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"4","key":"bib36-20260309","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/86342","article-title":"A CD14-independent LPS receptor cluster","volume":"2","year":"2001","journal-title":"Nat Immunol"},{"key":"bib37-20260309","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2019.06.008","article-title":"LRG1 promotes apoptosis and autophagy through the TGFbeta-smad1\/5 signaling pathway to exacerbate ischemia\/reperfusion injury","volume":"413","year":"2019","journal-title":"Neuroscience"},{"issue":"17","key":"bib38-20260309","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1177\/15353702221102117","article-title":"TFPI and FXIII negatively and S100A8\/A9 and cystatin C positively correlate with D-dimer in COVID-19","volume":"247","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"bib39-20260309","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2020.07.123","article-title":"Profilin-1 is dysregulated in endometroid (type I) endometrial cancer promoting cell proliferation and inhibiting pro-inflammatory cytokine production","volume":"531","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"bib40-20260309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/TA.0000000000002739","article-title":"Actin is associated with tissue injury in trauma patients and produces a hypercoagulable profile in vitro","volume":"89","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"bib41-20260309","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1074\/jbc.C110.181347","article-title":"Cyclophilin a (CyPA) induces chemotaxis independent of its peptidylprolyl cis-trans isomerase activity: direct binding between CyPA and the ectodomain of CD147","volume":"286","year":"2011","journal-title":"J Biol Chem"},{"issue":"25","key":"bib42-20260309","doi-asserted-by":"crossref","first-page":"22959","DOI":"10.1074\/jbc.M201593200","article-title":"Active site residues of cyclophilin a are crucial for its signaling activity via CD147","volume":"277","year":"2002","journal-title":"J Biol Chem"},{"issue":"7","key":"bib43-20260309","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.ATV.0000130664.51010.28","article-title":"Cyclophilin a is a proinflammatory cytokine that activates endothelial cells","volume":"24","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"bib44-20260309","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/SHK.0000000000002008","article-title":"Shock induces endothelial permeability after trauma through increased activation of Rhoa Gtpase","volume":"58","year":"2022","journal-title":"Shock"},{"issue":"5","key":"bib45-20260309","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cellsig.2009.01.009","article-title":"PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the MAPKAP kinase MK5","volume":"21","year":"2009","journal-title":"Cell Signal"},{"issue":"10","key":"bib46-20260309","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.275.10.7390","article-title":"Molecular and biochemical characterization of rat gamma-trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in carnitine biosynthesis","volume":"275","year":"2000","journal-title":"J Biol Chem"},{"key":"bib47-20260309","doi-asserted-by":"crossref","first-page":"108477","DOI":"10.1016\/j.abb.2020.108477","article-title":"Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1","volume":"691","year":"2020","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"bib48-20260309","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1074\/jbc.273.11.6297","article-title":"Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha","volume":"273","year":"1998","journal-title":"J Biol Chem"},{"issue":"7","key":"bib49-20260309","first-page":"1586","article-title":"A human erythrocyte-derived growth-promoting factor with a wide target cell spectrum: identification as catalase","volume":"55","year":"1995","journal-title":"Cancer Res"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:00:16Z","timestamp":1773043216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004792","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2024-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}